pre-seed
Stage
1
Investors
About
NearWave develops a handheld frequency domain near infrared spectroscopy (fdNIRS) device for non-invasive, deep tissue imaging to measure vital biomarkers like tissue oxygen saturation and hemoglobin concentrations for research and clinical applications.
Explore NearWave's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.